Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
European Radiology|March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning modelsGiulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
Prostate Cancer and Prostatic Diseases|February 25, 2026
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an "EMBARK-Like" cohortMatteo Droghetti, Valerio Pirelli, Francesco Ceci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2024
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysisTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Urology Oncology|October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European StudyPawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Urology Oncology|December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyLorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
European Radiology|March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning modelsGiulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
Prostate Cancer and Prostatic Diseases|February 25, 2026
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an "EMBARK-Like" cohortMatteo Droghetti, Valerio Pirelli, Francesco Ceci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2024
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysisTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Urology Oncology|October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European StudyPawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Urology Oncology|December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyLorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Pageof 15